Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis

Status Active, not recruiting

Clinical Trial Summary

In a Phase 2 Simon's Optimal Two-Stages Design intravenous tocilizumab will be administered as single 8mg/Kg dose in patients affected by severe multifocal interstitial pneumonia correlated to SARS-CoV2 infection. Aim of the study is to test the hypothesis that an anti-IL6 treatment can be effective in calming the virus-induced cytokine storm, blocking deterioration of lung function or even promoting a rapid improvement of clinical conditions, preventing naso-tracheal intubation and/or death.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04315480
Study type	Interventional
Source	Università Politecnica delle Marche
Contact
Status	Active, not recruiting
Phase	Phase 2
Start date	March 12, 2020
Completion date	May 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04584658` - Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Withdrawn	`NCT04456426` - Characteristics of Patients With COVID-19 in Meta State, Colombia
Terminated	`NCT04435457` - Cardiovascular Implications of COVID-19
Completed	`NCT04621058` - Efficacy of Vitamin D Treatment in Mortality Reduction Due to COVID-19.	Phase 3
Terminated	`NCT04403685` - Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers	Phase 3
Completed	`NCT04374565` - Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia	Phase 2
Not yet recruiting	`NCT04393051` - Baricitinib Compared to Standard Therapy in Patients With COVID-19	Phase 2
Completed	`NCT04405310` - Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial	Phase 2
Completed	`NCT04385901` - Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth	N/A
Completed	`NCT04445961` - Respiratory Mechanics and Gas Exchange in Patients With COVID-19 and Hypoxemic Acute Respiratory Failure
Completed	`NCT04665960` - Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2
Completed	`NCT04629703` - Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects	Phase 3
Completed	`NCT04764422` - Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand	Phase 1/Phase 2
Completed	`NCT04830800` - A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC	Phase 1/Phase 2
Terminated	`NCT04443673` - Glycine Supplement for Severe COVID-19	N/A
Withdrawn	`NCT04459702` - A Study of Combination Therapies to Treat COVID-19 Infection	Phase 2
Recruiting	`NCT04753619` - Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management	Phase 2
Withdrawn	`NCT04395716` - A Study of ResCure™ to Treat COVID-19 Infection	Phase 1
Completed	`NCT04358640` - Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey
Completed	`NCT04357340` - The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19	N/A